Zobrazeno 1 - 10
of 32
pro vyhledávání: '"E. G. Sazhina"'
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 78-84 (2024)
Intravenous immunoglobulins (IVIG) are the most commonly used immunobiological agents produced from donor blood. They were first used in the mid-twentieth century for the treatment of primary immunodeficiencies. Later, they were successfully used to
Externí odkaz:
https://doaj.org/article/b52aa5e365284425938f7a574378a2bc
Publikováno v:
Современная ревматология, Vol 15, Iss 5, Pp 108-113 (2021)
The article presents an analysis of modern data on the antinociceptive effectiveness of botulinum toxin type A (BTA) in rheumatic diseases (RD). The prospects for the use of BTA in the treatment of pain in different RDs are discussed. We searched for
Externí odkaz:
https://doaj.org/article/a0858f445812437e837ec32ad6b9f1f1
Publikováno v:
Современная ревматология, Vol 15, Iss 3, Pp 75-80 (2021)
Lipodermatosclerosis (LDS) is one of the variants of lobular panniculitis. The onset of LDS falls on the age of 50–60 years, when many patients already have comorbid pathology requiring complex therapy, which affects the course, the choice of treat
Externí odkaz:
https://doaj.org/article/a8dbb8310594459298b602275a15977f
Autor:
L. D. Vorobyeva, E. A. Aseeva, S. K. Solovyev, T. A. Belousova, N. E. Lopatina, E. G. Sazhina, G. V. Serikova
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 6, Pp 785-790 (2019)
Toxic epidermal necrolysis (TEN) has been long believed to be the most severe manifestation of drug allergy. However, cutaneous changes as TEN in systemic lupus erythematosus (SLE) were first described in the late 1970s. As of now, the English-langua
Externí odkaz:
https://doaj.org/article/ba68717e2b1b4d9cbcb082f699578410
Autor:
T. V. Beketova, M. A. Ushakova, N. Yu. Nikishina, A. N. Khelkovskaya-Sergeeva, E. V. Nikolaeva, E. G. Sazhina, T. M. Novoselova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 2, Pp 228-234 (2018)
Giant cell arteritis (GCA), formerly known as Horton's disease, is among the most common diseases from a group of systemic vasculitides; its clinical significance is complemented with the potential involvement of the coronary arteries, aorta, and cra
Externí odkaz:
https://doaj.org/article/5980e70fdedf4982a79f0e10cd8ead75
Autor:
E. A. Aseeva, A. I. Dubikov, L. A. Levasheva, G. M. Koilubaeva, M. K. Dzhetybaeva, V. T. Eralieva, E. R. Karimova, B. G. Isaeva, M. B. Kalykova, M. M. Saparbaeva, S. M. Isaeva, Zh. I. Omarbekova, E. S. Solovyeva, T. M. Reshetnyak, N. G. Klyukvina, T. V. Popkova, N. M. Kosheleva, T. A. Lisitsyna, T. A. Panafidina, E. V. Gerasimova, N. V. Seredavkina, L. V. Kondratyeva, E. V. Matyanova, M. E. Tsanyan, A. A. Mesnyakina, M. V. Letunovich, N. E. Lopatina, N. Yu. Nikishina, T. P. Fedina, E. G. Sazhina, S. I. Glukhova, S. K. Solovyev, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 5, Pp 520-526 (2016)
The article presents the data of international registries and cohort studies of systemic lupus erythematosus (SLE). It justifies the purpose and objectives of the international registry of SLE patients, a Eurasian cohort (RENAISSANCE), which was laun
Externí odkaz:
https://doaj.org/article/68cd356024e842a781c8b0c5c882b3e1
Autor:
E. A. Aseeva, S. K. Solovyev, N. G. Klyukvina, T. V. Popkova, G. M. Koilubaeva, T. M. Reshetnyak, N. M. Kosheleva, T. A. Lisitsyna, T. A. Panafidina, E. V. Gerasimova, N. V. Seredavkina, L. V. Kondratyeva, E. S. Solovyeva, M. E. Tsanyan, E. V. Matyanova, M. V. Letunovich, N. E. Lopatina, N. Yu. Nikishina, T. P. Fedina, E. G. Sazhina, S. I. Glukhova
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 4, Pp 404-411 (2016)
Objective: to reveal irreversible organ damages and to establish factors that influence their development in a RENAISSANCE cohort of patients with systemic lupus erythematosus (SLE) admitted to the clinic of the V.A. Nasonova Research Institute of Rh
Externí odkaz:
https://doaj.org/article/7b9b2fc18543445bbe1ddb1ee091282f
Autor:
T. V. Beketova, E. N. Aleksandrova, T. M. Novoselova, E. G. Sazhina, E. V. Nikolaeva, A. V. Smirnov, V. N. Sorotskaya, E. V. Zemerova, I. F. Nam, N. M. Nikitina, G. S. Arkhangelskaya, Z. R. Bagautdinova, I. N. Dashkov, S. Yu. Chernykh, O. V. Zhirnova, Yu. A. Lushpaeva, L. V. Masneva, I. P. Afanasieva, A. E. Arseniev, I. V. Kondratenko, I. B. Bashkova, S. I. Glukhova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 52, Iss 2, Pp 147-158 (2014)
In 2013, Russia registered officially the indications for the use of monoclonal antibodies to B-lymphocytes (rituximab, RTM) in systemic vasculitides associated with antineutrophil cytoplasmic antibodies (ANCA-SV). This communication presents the pre
Externí odkaz:
https://doaj.org/article/7eb2291aa58140549bd57c8bfa889109
Autor:
O A Antelava, A N Khelkovskaia-Sergeeva, G M Tarasova, N Iu Nikishina, N E Lopatina, S G Pal'shina, T P Fedina, E G Sazhina
Publikováno v:
Терапевтический архив, Vol 86, Iss 5, Pp 109-115 (2014)
Antisynthetase syndrome encompassing a symptom complex with severe interstitial lung disease is the severest subtype of polymyositis and dermatomyositis. The characteristic feature of antisynthetase syndrome is the insufficient efficiency of traditio
Externí odkaz:
https://doaj.org/article/fdd298322f1340a58456b5e76f6a73a6
Autor:
Olga Alekseyevna Antelava, G M Tarasova, E G Sazhina, Yu A Olyunin, R M Balabanova, E L Nasonov
Publikováno v:
Современная ревматология, Vol 3, Iss 4, Pp 54-58 (2009)
Polymyositis (PM) and dermatomyositis (DM) are autoimmune skeletal muscle diseases of unknown etiology, which are referred to as systemic connective tissue diseases and united under the common term Tidiopathic inflammatory myopathiesy. The most sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb592c676fcf48ae84fac7b8e1b74314
https://mrj.ima-press.net/mrj/article/view/259
https://mrj.ima-press.net/mrj/article/view/259